NCT00685412 - Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

March 31, 2011

Conditions

Papillomavirus Infections

Interventions

BIOLOGICAL

VGX-3100

DNA plasmid delivered via IM injection + electroporation using CELLECTRA device

Trial Locations (4)

Laurel Highlands, OB/GYN, P.C., Hopwood

University of Pennsylvania, Philadelphia

Lyndhurst Gynecologic Associates, Winston-Salem

Clinical Research Puerto Rico, San Juan